Display Settings:

Format

Send to:

Choose Destination
    Cancer Res. 2010 Oct 1;70(19):7353-9. Epub 2010 Sep 21.

    PALB2/FANCN: recombining cancer and Fanconi anemia.

    Source

    Department of Oncology, McGill University, Montreal, Quebec, Canada. marc.tischkowitz@mcgill.ca

    Abstract

    Partner and localizer of BRCA2 (PALB2) was originally identified as a BRCA2-interacting protein that is crucial for key BRCA2 genome caretaker functions. It subsequently became clear that PALB2 was another Fanconi anemia (FA) gene (FANCN), and that monoallelic PALB2 mutations are associated with increased risk of breast and pancreatic cancer. Mutations in PALB2 have been identified in breast cancer families worldwide, and recent studies have shown that PALB2 also interacts with BRCA1. Here, we summarize the molecular functions and clinical phenotypes of this key DNA repair pathway component and discuss how its discovery has advanced our knowledge of both FA and adult cancer predisposition.

    © 2010 AACR.

    PMID:
    20858716
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2948578
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk